desk
Share
News Topical, Digital Desk : Natco Pharma, a pharma company included in the BSE 500 index, has released its quarterly results. The company announced its results after the market closed on Wednesday. According to the information given by the company, the quarterly profit of the company has increased by 5 percent compared to last year. At the same time, the company's income has increased by more than 14 percent on a year-on-year basis. EBITDA has increased by more than 10 percent compared to last year. At the same time, a slight weakness has been seen in the margin. Before the results, the company's stock saw a decline and the stock closed down by about 2 percent in Wednesday's trading.
How were the quarterly results?
The company's profit has increased by 5 percent compared to last year and has increased from Rs 386.3 crore to Rs 406 crore on a year-on-year basis. The company's income has increased by 14.3 percent compared to last year and has increased from Rs 1068 crore to Rs 1221 crore compared to last year. There has also been an increase in EBITDA and it has increased by 10.2 percent compared to last year. In the March quarter, EBITDA was at Rs 548 crore, which was at Rs 497.3 crore a year ago. The company's quarterly margins have been at 44.89 percent, which was at 46.55 percent a year ago. Along with this, the total expenses of the company have increased from Rs 632.7 crore to Rs 781.4 crore. That is, there has been an increase of 23.5 percent on a year-on-year basis.
How was the performance of the stock? In Wednesday's trading, the stock closed at 862.45 on the BSE with a decline of 1.78 percent. A year ago, the stock was above the 1000 level. The stock reached its lowest level of 660 in April this year. At the same time, the stock's upper level of the year is 1638.
--Advertisement--
